TELA - רווח נקי למניה (EPS TTM) TELA Bio Corp
Will AI-driven production robotization fuel growth for TELA Bio, Inc. (TELA)? The answer lies in surgeon loyalty to bio-meshes and the annual net income per share trend on GURU.Markets, where the metric value stands at -0.74. Success is based on reducing surgical recurrence rates. Ultimately, the primary drivers will be the expansion of OviTex and the broadening of insurance coverage in the US.
TELA (TELA Bio Corp): פילוחים אנליטיים ודוחות לפי אינדיקטורים
A portfolio analyst utilizes this metric to filter for fundamentally resilient assets within the biomedicine sector. The indicator is calculated as the ratio of total net income over a rolling year to the number of shares outstanding. For TELA Bio, Inc. (TELA), high operating expenses related to the commercial sales force offset revenue growth, resulting in a negative figure. Analyzing the net income per share over the last 12 months allows for an assessment of the capital burn rate. The trend of this line determines the actual timeframe for TELA Bio, Inc. (TELA) to reach its break-even point.
